Correlation Between XTL Biopharmaceutica and MetLife

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both XTL Biopharmaceutica and MetLife at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XTL Biopharmaceutica and MetLife into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between XTL Biopharmaceuticals and MetLife, you can compare the effects of market volatilities on XTL Biopharmaceutica and MetLife and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XTL Biopharmaceutica with a short position of MetLife. Check out your portfolio center. Please also check ongoing floating volatility patterns of XTL Biopharmaceutica and MetLife.

Diversification Opportunities for XTL Biopharmaceutica and MetLife

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between XTL and MetLife is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding XTL Biopharmaceuticals and MetLife in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MetLife and XTL Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XTL Biopharmaceuticals are associated (or correlated) with MetLife. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MetLife has no effect on the direction of XTL Biopharmaceutica i.e., XTL Biopharmaceutica and MetLife go up and down completely randomly.

Pair Corralation between XTL Biopharmaceutica and MetLife

Assuming the 90 days trading horizon XTL Biopharmaceuticals is expected to generate 13.09 times more return on investment than MetLife. However, XTL Biopharmaceutica is 13.09 times more volatile than MetLife. It trades about 0.12 of its potential returns per unit of risk. MetLife is currently generating about 0.1 per unit of risk. If you would invest  340.00  in XTL Biopharmaceuticals on January 17, 2024 and sell it today you would earn a total of  660.00  from holding XTL Biopharmaceuticals or generate 194.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy82.11%
ValuesDaily Returns

XTL Biopharmaceuticals  vs.  MetLife

 Performance 
       Timeline  
XTL Biopharmaceuticals 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in XTL Biopharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, XTL Biopharmaceutica sustained solid returns over the last few months and may actually be approaching a breakup point.
MetLife 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in MetLife are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical and fundamental indicators, MetLife is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

XTL Biopharmaceutica and MetLife Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with XTL Biopharmaceutica and MetLife

The main advantage of trading using opposite XTL Biopharmaceutica and MetLife positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XTL Biopharmaceutica position performs unexpectedly, MetLife can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MetLife will offset losses from the drop in MetLife's long position.
The idea behind XTL Biopharmaceuticals and MetLife pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities